Catonsville, MDNCT05527210Now EnrollingIRB Ready

Schizophrenia Clinical Trial in Catonsville, MD

Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Catonsville. Study-provided care at no cost to qualified participants.

Sponsored by University of Maryland, Baltimore

Quick Self-Assessment

See if you qualify for this Catonsville location

Preparing your pre-screening questions…

Expert Care in Catonsville

Access schizophrenia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related schizophrenia treatment provided free

Apply for This Catonsville Location

Check if you qualify for this schizophrenia clinical trial in Catonsville, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Catonsville

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Catonsville site if eligible
  4. 4Begin participation

About This Schizophrenia Study in Catonsville

The proposed project is based on the observation that schizophrenia is characterized by a chronic pro-inflammatory state, which contributes to the severity of a number of the clinical manifestations of the illness, including cognitive impairments, the treatment of which represents a critically important unmet therapeutic need.

Sponsor: University of Maryland, Baltimore

Who Can Participate

Inclusion Criteria

DSM-5 diagnosis of schizophrenia or schizoaffective disorder;
Age 18-60 years;
Considered clinically stable by the treating psychiatrist;
Currently treated with an antipsychotic, with no dose changes in last 14 days;
Ability to participate in the informed consent process, as determined by a score of 10 or greater on the Evaluation to Sign Consent;

Exclusion Criteria

Gastrointestinal disorders, including, but not limited to Crohn's Disease, Irritable Bowel Syndrome, Celiac Disease, whose pathology or treatment could alter the presentation or treatment of schizophrenia or significantly increase the risk associated with the proposed treatment protocol
Organic brain disorder, including cerebrovascular accident; epilepsy; traumatic brain injury, Loss of consciousness (LOC) for more than 30 minutes
Intellectual disability
Acute antibiotic use
Immune therapy within the last three months
Prebiotic or probiotic treatment within the last three months
Inability to understand English
Inability to cooperate with study procedures
Pregnant or lactation secondary to pregnancy
Participants who meet DSM 5 criteria for alcohol or substance misuse (except caffeine and nicotine) within the last 3 months will be excluded. Participants who meet DSM 5 criteria for marijuana misuse - mild will be included in the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Catonsville?

Yes, this clinical trial (NCT05527210) has an active research site in Catonsville, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Schizophrenia Treatment Options in Catonsville, MD

If you're searching for schizophrenia treatment options in Catonsville, MD, this clinical trial (NCT05527210) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Catonsville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all schizophrenia clinical trials near you to find additional studies recruiting in your area.

More Schizophrenia Trials in Catonsville, MD

See all schizophrenia clinical trials recruiting in Catonsville — not just this study.

Browse Schizophrenia Trials in Catonsville →

Browse More Trials by Condition

Schizophrenia TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Catonsville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Catonsville, MD